Ind-Swift Laboratories Ltd.
Snapshot View

View in App

Prices View details >>

58.80 +0.16 ▲0.3%

21 March 2023, 04:01:00 PM
Volume: 7,417

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.indswiftlabs.com
Market Cap 347.43 Cr.
Enterprise Value(EV) 1,263.13 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 1.91 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 30.84 Trailing Twelve Months Ending 2022-12
Industry PE 31.70 Trailing Twelve Months Ending 2022-12
Book Value / Share 80.66 Trailing Twelve Months Ending 2022-12
Price to Book Value 0.73 Calculated using Price: 58.80
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 5.91 Cr. 59,086,860 Shares
FaceValue 10
Company Profile
Ind-Swift Laboratories is a part of the Ind-swift Group and is based at Chandigarh, India. It has been promoted by Ind-Swift Limited in a joint venture with the Punjab State Industrial Development Corporation Limited (PSIDC). The group has established a strong reputation as innovators in the Indian pharmaceutical industry.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.27%
1 Week
-2.68%
1 Month
-10.37%
3 Month
-8.34%
6 Month
-1.26%
1 Year
-13.15%
2 Year
-23.88%
5 Year
-0.76%
10 Year
+31.10%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -27.88 -36.36 -23.11 -15.89 7.89 8.99 -5.56 -0.78 -0.54
Return on Capital Employed (%) -1.46 -1.52 1.40 2.19 4.59 9.25 5.97 8.31 7.85
Return on Assets (%) -5.18 -5.22 -2.65 -1.86 1.11 1.53 -1.17 -0.18 -0.12

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 725 595 517 531 553 588 641 604 601 646
Non Curr. Liab. 983 811 717 495 438 901 828 840 814 777
Curr. Liab. 630 833 951 1,005 936 356 323 315 335 342
Minority Int. 0 0 0
Equity & Liab. 2,339 2,239 2,185 2,031 1,927 1,845 1,792 1,758 1,749 1,766
Non Curr. Assets 1,350 1,319 1,264 1,202 1,088 1,009 929 814 673 648
Curr. Assets 989 920 922 829 839 836 863 942 1,074 1,117
Misc. Exp. not W/O
Total Assets 2,339 2,239 2,185 2,031 1,927 1,845 1,792 1,758 1,749 1,766

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 965 660 653 697 763 757 780 891 1,039 1,210
Other Income 14 22 16 23 26 37 33 23 43 45
Total Income 979 683 669 720 788 794 813 914 1,082 1,254
Total Expenditure -906 -572 -546 -591 -628 -630 -636 -709 -843 -1,008
PBIDT 73 111 123 129 160 163 177 206 239 247
Interest -117 -117 -106 -90 -35 -92 -107 -100 -96 -94
Depreciation -66 -84 -85 -88 -87 -104 -90 -87 -131 -130
Taxation 20 24 24 16 -14 -21 -1 -21 -15 -12
Exceptional Items -33 -53 -15 -5 -2 83
PAT -122 -119 -59 -39 22 29 -21 -3 -2 11
Minority Interest
Share Associate 0
Other Related Items
Consolidated Net Profit -122 -119 -59 -39 22 29 -21 -3 -2 11
Adjusted EPS -30 -29 -14 -9 5 6 -4 -1 0 2

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -47 66 98 79 96 73 -64 125 135 150
Cash Fr. Inv. -48 -27 -36 -30 -31 -17 -12 -9 -10 5
Cash Fr. Finan. 66 -38 -64 -48 -69 -62 100 -133 -124 -141
Net Change -29 0 -1 2 -4 -6 23 -17 1 14
Cash & Cash Eqvt 18 21 20 22 16 9 30 11 12 26

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 42.00 42.00 42.00 42.00 42.00 42.00 42.00 42.00 42.00
Public 58.00 58.00 58.00 58.00 58.00 58.00 58.00 58.00 58.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 86.87 86.87 86.87 86.87 86.87 86.81 86.84 86.84 86.84

Announcements View Details >>

Wed, 01 Mar 2023
Compliances-Reg. 57 (1) - Certificate of interest payment/Principal in case of NCD
Intimation under Regulation 57(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Tue, 14 Feb 2023
Board Meeting Outcome for Outcome Of Board Meeting As On 14.02.2023
Outcome of Board Meeting as on 14.02.2023
Tue, 14 Feb 2023
Unaudited Result For The Quarter Ended 31St Dec 2022
unAudited Result for the quarter ended 31st Dec 2022

Technical Scans View Details >>

Tue, 21 Mar 2023
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 229,424.41 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. 73,593.21 4,419.30 -0.5%
Divi's Laboratories Ltd. 73,553.38 2,773.45 -0.9%
Cipla Ltd. 69,632.88 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. 61,491.67 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. 51,277.87 1,518.00 -0.3%
Zydus Lifesciences Ltd. 48,378.30 477.95 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 54.47 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.20 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 30.72 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-12 26.39 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 80.34 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 61.82 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.47 477.95 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.15 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.34 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 5.92 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-12 3.07 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 9.96 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.06 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.80 477.95 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-03 0.04 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 477.95 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-03 13.10 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 477.95 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-03 13.10 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 477.95 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-03 21,763.34 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 477.95 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 956.20 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,419.30 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,773.45 -0.9%
Cipla Ltd. Consolidated 2022-03 2,559.47 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 477.95 +0.4%

FAQ's On Ind-Swift Laboratories Ltd.

What is Ind-Swift Lab. share price?
Can I buy Ind-Swift Lab. shares now?
What is the Market Cap of Ind-Swift Lab.?
What are the key metrics to analyse Ind-Swift Lab.?
What is the 52 Week High and Low of Ind-Swift Lab.?
What is the trend of Ind-Swift Lab. share price?